Kevin Balthaser, CFO: Aclaris Therapeutics ACRS Sell · Filed 23/03/03

Trade details

Type: Insider sale
Amount: $11,291.22
Shares · price: 894 sh · $12.63 a share
Held after: 5,256 sh
Stock: Aclaris Therapeutics ACRS
Person: Kevin BalthaserCFO
Trade date: 23/03/03
Filed: 23/03/03
Days to filing: 0 days

Sold 14.5% of holdings

Share of holding sold: 14.5%

Aclaris Therapeutics trades, last 26 weeks

What else happened in Aclaris Therapeutics around then

Filed or reported within 30 days of the trade day · 23/02/01~23/04/02

Kevin Balthaser's recent trades

Kevin BalthaserCFO
BuyAclaris Therapeutics
Buy
Aclaris Therapeutics
ACRS
$75K
9,490 sh
$75K
Filed 23/09/07
Traded 23/09/06
Kevin BalthaserCFO
SellAclaris Therapeutics
Sell
Aclaris Therapeutics
ACRS
$12.3K
1,000 sh
$12.3K
Filed 23/03/03
Traded 23/03/02